Literature DB >> 15475684

Tau epitope display in progressive supranuclear palsy and corticobasal degeneration.

R W Berry1, A P Sweet, F A Clark, S Lagalwar, B R Lapin, T Wang, S Topgi, A L Guillozet-Bongaarts, E J Cochran, E H Bigio, L I Binder.   

Abstract

Filamentous aggregates of the protein tau are a prominent feature of Alzheimer's disease (AD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). However, the extent to which the molecular structure of the tau in these aggregates is similar or differs between these diseases is unclear. We approached this question by examining these disorders with a panel of antibodies that represent different structural, conformational, and cleavage-specific tau epitopes. Although each of these antibodies reveals AD pathology, they resolved into three classes with respect to PSP and CBD: AD2 and Tau-46.1 stained the most tau pathology in all cases; Tau-1, 2, 5, and 12 exhibited variable reactivity; and Tau-66 and MN423 did not reveal any tau pathology. In addition, hippocampal neurofibrillary tangles in these cases showed a predominantly PSP/CBD-like, rather than AD-like, staining pattern. These results indicate that the patterns of the tau epitopes represented by this panel that reside in the pathological aggregates of PSP and CBD are similar to each other but distinct from that of AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475684     DOI: 10.1023/B:NEUR.0000044190.96426.b9

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  27 in total

1.  Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.

Authors:  David J Irwin; Alberto Lleó; Sharon X Xie; Corey T McMillan; David A Wolk; Edward B Lee; Viviana M Van Deerlin; Leslie M Shaw; John Q Trojanowski; Murray Grossman
Journal:  Ann Neurol       Date:  2017-08-19       Impact factor: 10.422

2.  Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.

Authors:  David J Irwin; Todd J Cohen; Murray Grossman; Steven E Arnold; Sharon X Xie; Virginia M-Y Lee; John Q Trojanowski
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

3.  Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases.

Authors:  Nicholas M Kanaan; Gerardo A Morfini; Nichole E LaPointe; Gustavo F Pigino; Kristina R Patterson; Yuyu Song; Athena Andreadis; Yifan Fu; Scott T Brady; Lester I Binder
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

4.  Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport.

Authors:  Chelsea T Tiernan; Benjamin Combs; Kristine Cox; Gerardo Morfini; Scott T Brady; Scott E Counts; Nicholas M Kanaan
Journal:  Exp Neurol       Date:  2016-06-30       Impact factor: 5.330

5.  Selective tau tyrosine nitration in non-AD tauopathies.

Authors:  Juan F Reyes; Changiz Geula; Laurel Vana; Lester I Binder
Journal:  Acta Neuropathol       Date:  2011-11-06       Impact factor: 17.088

6.  Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport.

Authors:  Kristina R Patterson; Sarah M Ward; Benjamin Combs; Kellen Voss; Nicholas M Kanaan; Gerardo Morfini; Scott T Brady; T Chris Gamblin; Lester I Binder
Journal:  Biochemistry       Date:  2011-11-08       Impact factor: 3.162

7.  Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.

Authors:  Kristina R Patterson; Christine Remmers; Yifan Fu; Sarah Brooker; Nicholas M Kanaan; Laurel Vana; Sarah Ward; Juan F Reyes; Keith Philibert; Marc J Glucksman; Lester I Binder
Journal:  J Biol Chem       Date:  2011-05-06       Impact factor: 5.157

8.  Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition.

Authors:  Kristine Cox; Benjamin Combs; Brenda Abdelmesih; Gerardo Morfini; Scott T Brady; Nicholas M Kanaan
Journal:  Neurobiol Aging       Date:  2016-07-29       Impact factor: 4.673

9.  A possible link between astrocyte activation and tau nitration in Alzheimer's disease.

Authors:  Juan F Reyes; Matthew R Reynolds; Peleg M Horowitz; Yifan Fu; Angela L Guillozet-Bongaarts; Robert Berry; Lester I Binder
Journal:  Neurobiol Dis       Date:  2008-05-02       Impact factor: 5.996

10.  Basic fibroblast growth factor elicits formation of interstitial axonal branches via enhanced severing of microtubules.

Authors:  Liang Qiang; Wenqian Yu; Mei Liu; Joanna M Solowska; Peter W Baas
Journal:  Mol Biol Cell       Date:  2009-11-25       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.